Collagenase SANTYL Ointment Website
Healthpoint Biotherapeutics’ Collagenase SANTYL Ointment is the only FDA-approved enzymatic wound debrider on the market. This website and accompanying collateral were designed as part of SANTYL’s “micro-debridement” campaign, a unique phrase coined by HLG to define efficacy beyond the removal of visible, necrotic tissue at the surface. This website further supports SANTYL’s selective micro-debridement with mechanism of action and application videos, case studies, and other interactive features.
OASIS Wound Matrix and OASIS Ultra Tri-Layer Matrix Website
Because Healthpoint Biotherapeutics’ OASIS Wound Matrix and OASIS Ultra Tri-Layer Matrix have similar benefits but are optimized for different wound types, designing the website presented the challenge of maintaining a common brand essence for both products while differentiating their intended uses. The lifelike figure featured on the homepage employs an interactive method of communicating the different applications for the brands, and acts as the entry point into the two different web portals.
Accuzyme SE Wound Debridement Campaign
This award-winning campaign for the launch of the spray emulsion line extension of Healthpoint’s Accuzyme wound debrider emphasizes the precise and thorough delivery of rapid, penetrating, and powerful necrotic eschar removal.
Panafil SE Wound Debridement Campaign
The launch campaign for this line extension of Healthpoint’s Panafil effectively communicated the precise spray emulsion delivery of a dual action wound debrider—the powerful and continuous removal of necrotic debris accompanied by the nurturing and protection of healthy granulation tissue.